SIGLEC16
Sialic acid-binding Ig-like lectin 16
Also known as: SIG16_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- A6NMB1
- Gene
- SIGLEC16
- Canonical length
- 481 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
No narrative summary is available for SIGLEC16 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
481 residues, UniProt reviewed canonical sequence.
>A6NMB1|SIGLEC16
1 MLLLPLLLPV LGAGSLNKDP SYSLQVQRQV PVPEGLCVIV SCNLSYPRDG WDESTAAYGY
61 WFKGRTSPKT GAPVATNNQS REVAMSTRDR FQLTGDPGKG SCSLVIRDAQ REDEAWYFFR
121 VERGSRVRHS FLSNAFFLKV TALTQKPDVY IPETLEPGQP VTVICVFNWA FKKCPAPSFS
181 WTGAALSPRR TRPSTSHFSV LSFTPSPQDH DTDLTCHVDF SRKGVSAQRT VRLRVASLEL
241 QGNVIYLEVQ KGQFLRLLCA ADSQPPATLS WVLQDRVLSS SHPWGPRTLG LELPGVKAGD
301 SGRYTCRAEN RLGSQQRALD LSVQYPPENL RVMVSQANRT VLENLRNGTS LRVLEGQSLR
361 LVCVTHSSPP ARLSWTWGEQ TVGPSQPSDP GVLQLPRVQM EHEGEFTCHA RHPLGSQRVS
421 LSFSVHCKSG PMTGVVLVAV GEVAMKILLL CLCLILLRVR SCRRKAARAA LGMEAADAVT
481 DLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SIGLEC16 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- ovary: 22 nTPM
- spleen: 6.1 nTPM
- appendix: 1.9 nTPM
- lung: 1.4 nTPM
- liver: 0.9 nTPM
- smooth muscle: 0.9 nTPM
Single-cell type
- kupffer cells: 25 nCPM
- late spermatids: 19 nCPM
- ovarian stromal cells: 15 nCPM
- monocytes: 11 nCPM
- macrophages: 7.7 nCPM
- microglia: 4.7 nCPM
Immune cell
- non-classical monocyte: 2.9 nTPM
- eosinophil: 1.3 nTPM
- intermediate monocyte: 1.1 nTPM
- neutrophil: 0.7 nTPM
- basophil: 0.3 nTPM
- classical monocyte: 0.3 nTPM
Brain region
- thalamus: 4.7 nTPM
- white matter: 4.4 nTPM
- choroid plexus: 4.3 nTPM
- medulla oblongata: 4.2 nTPM
- cerebral cortex: 4.1 nTPM
- basal ganglia: 4 nTPM
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell adhesion
- positive regulation of defense response to bacterium
- positive regulation of interleukin-6 production
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Immunoglobulin/major histocompatibility complex, conserved site
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Immunoglobulin-like domain
- Immunoglobulin I-set
- Immunoglobulin V-set domain
- Immunoglobulin-like fold
- Immunoglobulin-like domain superfamily
- Sialic acid-binding Ig-like lectin
- Immunoglobulin I-set domain
- Immunoglobulin V-set domain
- Immunoglobulin domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SIGLEC16 as an antibody target. Whether an autoantibody or antibody against SIGLEC16 could matter depends on whether native SIGLEC16 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SIGLEC16 is annotated at the cell surface, where native SIGLEC16 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SIGLEC16 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...